Pregnancy in patients with tuberculosis: A TBNET cross-sectional survey by Bothamley, Graham H. et al.
RESEARCH ARTICLE Open Access
Pregnancy in patients with tuberculosis: a
TBNET cross-sectional survey
Graham H. Bothamley1*, Cordula Ehlers2, Irina Salonka3, Alena Skrahina3, Angels Orcau4, Luigi R. Codecasa5,
Maurizio Ferrarese5, Dragica Pesut6, Ivan Solovic7, Andrii Dudnyk8, Luis Anibarro9, Claudia Denkinger10,
Lorenzo Guglielmetti11, Inge Muylle12 and Marco Confalonieri13
Abstract
Background: Objectives: To determine whether the incidence of tuberculosis with pregnancy is more common
than would be expected from the crude birth rate; to see whether there is significant delay in the diagnosis of
tuberculosis during pregnancy.
Method: Design: A cross-sectional survey. Setting: 13 tuberculosis clinics within different European countries and
the USA. Population/sample: All patients with tuberculosis seen at these clinics for a period > 1 year. Instrument:
Questionnaire survey based on continuous data collection. Main outcome measures: number and proportion of
women with tuberculosis who were pregnant; timing of diagnosis in relation to pregnancy, including those who
were pregnant or delivered in the 3 months prior to the diagnosis of TB and those who developed TB within
3 months after delivery.
Results: Pregnancy occurred in 224 (1.5 %) of 15,217 TB patients and followed the expected rate predicted from
the crude birth rate for the clinic populations. TB was diagnosed more commonly in the 3 months after delivery
(n = 103) than during pregnancy (n = 68; χ2 = 25.1, P < 0.001).
Conclusions: TB is diagnosed more frequently after delivery, despite variations in local TB incidence and healthcare
systems.
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Background
Tuberculosis most commonly affects women during
their reproductive years [1]. Pregnancy during the treat-
ment of tuberculosis was formerly more common due to
the interaction between the oral contraceptive pill and
rifampicin, such that the former was no longer effective
[2]. In pregnancy there is also a shift from cell-mediated
(Th1) immunity, which protects against tuberculosis [3],
to antibody-mediated (Th2) immunity [4–6], making
reactivation of latent tuberculosis and susceptibility to
recent infection progressing to active disease more
likely.
The diagnosis of tuberculosis is often delayed as many
of the symptoms are non-specific and may be present
during normal pregnancy, e.g. tiredness, feeling hot and
sweating at night [7]. Exposure of the fetus to x-rays
from chest radiography raises concerns in pregnant
women and health care workers [8] and so the usual
process of diagnosis for those with a cough may be
delayed. The World Health Organization recommends
screening for tuberculosis in those with HIV co-
infection and those with symptoms of tuberculosis using
two-three sputum smears stained for tubercle bacilli
and/or PCR tests for tuberculosis such as Xpert MTB/
RIF [9]. However, the sputum smear is less frequently
positive during pregnancy than in others with tubercu-
losis [10]; the value of PCR tests is in the early stages of
evaluation [11]. Extrapulmonary tuberculosis requires
tissue sampling and culture and screening pregnant
women with symptoms is often provoked by a positive
tuberculin skin test or interferon-gamma release assay
[12]. Estimates have suggested that 26 % of all prevent-
able deaths in pregnancy worldwide are directly attribut-
able to tuberculosis [13] and children are especially
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susceptible to forms of tuberculosis with a high mortal-
ity [14]. Late diagnosis of active tuberculosis in pregnant
women has significant cost implications. The possible
transmission of tuberculosis to the baby and also to
other mothers and their children requires extensive
contact tracing and constitutes a “serious untoward
incident”.
Our aim was to determine whether tuberculosis was in
fact more common in pregnancy and whether the devel-
oped health care systems in Europe and the United
States were still associated with a diagnostic delay of
tuberculosis in pregnant women.
Methods
Study design
Cross-sectional survey.
Setting
The Tuberculosis Network European Trialsgroup (TBNET;
http://www.tb-net.org/) is made up of >650 physicians who
wish to participate in clinical trials in tuberculosis and who
therefore aim to maintain accurate data regarding their
patients [15]. A survey of TBNET members was conducted
to review clinical records of those with tuberculosis from 1
September 2008 to 31 August 2013 if possible, or at least
for a period of one year or more.
Participants
Participants were required to have recorded routinely
whether patients were pregnant or not and, from contact
tracing records, to be able to determine whether they
were breastfeeding infants. Only clinics with at least one
year of data and with >30 patients were included. Local
ethical advice was sought; the study deemed an audit
promoting good medical care.
Variables
The data collected included the total number of
patients with tuberculosis and the number who were
pregnant during treatment for tuberculosis or within
3 months of delivering a child (mycobacterial culture may
take up to 6 weeks to make the diagnosis of tuberculosis
and hence the extended time period of 3 months rather
than the standard 6 weeks postpartum period) or pregnant
within 3 months of completing treatment for tuberculosis.
The categories were such that if a pregnant woman
decided not to continue with the pregnancy, the figures
would still be included as “pregnant with tuberculosis”.
Expected values were derived from the World Bank
website containing 2010–2015 data for the crude birth
rate [16].
Statistics
Participation was sought through an on-line question-
naire (SurveyMonkey.co.uk). Data were then re-entered
on a standardized excel chart (Microsoft Office 2007).
Data were checked again by asking for clarification of
individual entries and at the stage of preparation of the
Table. Where there were large numbers, e.g. Belarus,
two authors were included to indicate the role of both in
ascertaining integrity of the data. A χ2-squared value was
calculated using the formula (observed - expected)2/(ex-
pected) (GraphPad Software Inc. 2×2 contingency tables).
Results
Thirteen sites provided data (Fig. 1), two clinics being in
the same city of Milan. Numbers of patients with tuber-
culosis varied from 103 to 5,500 from data collected over
a year (3 clinics), 3 years (3 clinics) or ≥5 years (7 clinics)
(Table 1). The survey identified 224 who satisfied the
criteria for inclusion in the study out of a denominator
of 15,217 tuberculosis patients (1.5 %; median 0.7 %,
range 0–3.1 %, with the Belgian clinic as an outlier at
11.1 %). The combined data showed that the number of
pregnancies in those with tuberculosis was close to that
predicted by the crude birth rate for the denominator
(227; Table 1), but there were significant variations from
country to country.
Sixty-eight had a diagnosis of tuberculosis during
pregnancy (0.5 % all tuberculosis cases; 30 % of total
included in the study, average 7.5 per calendar month
(p.c.m.) for all pregnancies with tuberculosis) compared
to 103 diagnosed with tuberculosis within 3 months of
delivery (34.3 p.c.m.; χ2 = 25.1, P < 0.001). The number of
patients recorded as having become pregnant within
3 months of completing tuberculosis treatment (53/3,
i.e. 17.7 p.c.m.) was also higher but did not differ
Fig. 1 Flow chart of data collection
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significantly from the combined average per month for
pregnancy and the 3-month period after delivery (171/
12, i.e. 14.3 p.c.m., χ2 = 0.8, P > 0.1). Tuberculosis was
diagnosed more frequently during pregnancy in Belgium
and the United Kingdom, and Ukraine less frequently
than expected from the combined data (χ2 = 6.3, 6.1 and
10.3, respectively, P <0.05). For individual countries,
excluding those with less than 5 cases of tuberculosis diag-
nosed during pregnancy, again Belgium and the United
Kingdom showed no significant difference in rate compared
to the 3 months before and after pregnancy (all χ2 ≤ 3.3,
P > 0.05).
Discussion
Main findings
The most important finding is that tuberculosis is diag-
nosed less frequently during pregnancy than in the post-
partum period. The rate of tuberculosis in pregnancy did
not differ significantly when compared to the crude birth
rate.
Interpretation
There are several possible reasons for a late diagnosis of
tuberculosis. Late booking for antenatal care amongst
the population most likely to acquire tuberculosis may
follow the inverse care law, whereby those in greatest
need of medical care are least likely to access it [17, 18].
The population at risk of tuberculosis may have a poorer
uptake of antenatal care and therefore be only suscep-
tible to diagnosis at or shortly after delivery [10]. In a
multicultural qualitative study close to the UK clinic,
issues of ambivalence, lack of self worth and empower-
ment, common in patients with tuberculosis, have been
recorded as reasons for delay in antenatal care [19].
The lower rate of diagnosis of tuberculosis during
pregnancy compared to the 3 month postpartum period
raises concerns. There may still be a reluctance to inves-
tigate pregnant women for tuberculosis, especially by
performing a chest x-ray even though radiation doses
are much reduced and the fetus can be shielded with a
lead apron [4, 20]. A UK cohort study of 5.5 % of the
total population also observed more tuberculosis notifi-
cations after pregnancy, documenting 22 diagnoses of
tuberculosis during pregnancy and 22 in the 6 months
post partum, rising to a peak at 90 days and falling
thereafter [21]. These authors also noted that the post-
partum increase in tuberculosis might be due to a delay
in diagnosis.
An alternative reason for an increase in tuberculosis
during the postpartum period might be that the immuno-
logical changes in pregnancy might allow latent tubercu-
losis infection to reactivate, a process which might take
several weeks to pass from latent to subclinical disease
and thence to active tuberculosis. In general, in pregnancy
Table 1 Expected and actual numbers of pregnancies with concurrent TB
Country No. of TB
patients
Crude
birth rate
(per 1,000 per year)[16]
Expected number
of pregnant
TB patientsb
During: TB
diagnosed
during
pregnancy
Before: Pregnant
within 3 months
of completing TB
treatment
After: TB diagnosed
within 3 months
after delivery
Predicted
number of
pregnant TB
for 1.25 yrs
Total in
study
Belarus 5500 13 54.9 15 16 6 89.4 37
Belgium 143 12 1.3 11 0 5 2.2 16
Italy (3 cities)
A 1860 1 7 2 10
B 217 1 4 0 5
C 103 0 1 1 2
Sub-total 2180 9 15.1 2 12 3 24.5 17
Serbia 1353 9 9.4 2 0 1 15.3 3
Slovakia 1197 11 10.1 4 4 21 16.6 29
Spain (2 cities)
A 1946 2 3 5 10
B 374 0 1 2 3
Sub-total 2320 10 17.8 2 4 7 29.0 13
Ukraine 500 11 4.2 3 10 35 6.9 48
United Kingdom 1774 18a 24.5 29 7 20 39.8 56
USA 250 13 2.5 0 0 5 3.3 5
Total 15,217 n/a 139.8 68 53 103 227.0 224
aLocal birth rate (UK crude birth rate 12 per 1,000)
b = no. of TB patients x crude birth rate x (280 days per pregnancy/365 days per year)
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there is a shift from cell-mediated (Th1) immunity to
antibody-mediated (Th2) immunity. Whilst the role of
immunity in successful pregnancy is undoubtedly more
complex, involving Treg cells with specificity for allogeneic
antigens expressed by the fetus and NK cells [22, 23],
HLA-G [24] and macrophages and dendritic cells [25],
reduced levels of the pro-inflammatory cytokine IL-17
may also contribute to the likelihood of developing tuber-
culosis [26–28].
The burden of tuberculosis in pregnancy has been esti-
mated from data available from the World Health
Organization [29]. Using data for age and sex, birth rate
and case notification by age and sex, the rate of tubercu-
losis was estimated at of 2.1 globally, 0.4 in the Americas
and in Europe 0.6 per 1,000 pregnant women. Notably,
the prevalence of tuberculosis was similar in the whole
population to that in women aged 15–44 years. The pre-
dicted rate of pregnancy in women with tuberculosis
would therefore be comparable to the crude birth rate x
the number of days pregnant in a year (their estimate
280/365), i.e. 0.7–2.5 per 100 TB patients within the
World Health Organization European Region.
Antenatal care is often the first occasion that women
contact health services and thus has been suggested as a
point at which verbal screening regarding symptoms of
and risk factors for tuberculosis could occur in high risk
populations [12, 30]. World Health Organization guide-
lines on screening for tuberculosis have emphasized
those with human immunodeficiency virus infection and
contacts of those with pulmonary tuberculosis, with
consideration of migrants from high burden countries
(tuberculosis incidence > 100 per 100,000) as well as
prisoners, health care workers, homeless and illicit drug
users [31]. Even in low tuberculosis incidence countries,
screening for tuberculosis infection with an interferon-
gamma release assay is considered cost effective [32].
Strengths and limitations
This is one of the largest surveys of pregnancy and
tuberculosis to date (systematic reviews were identified
from PubMed using the search terms “pregnancy”, “tu-
berculosis” and “review”; individual publications noted
to have >224 cases were then examined for the actual
number of subjects with both TB and pregnancy; two
publications had greater numbers [33, 34]). By including
the 3 months before and after pregnancy, any bias due
to an adverse outcome of pregnancy or a woman’s deci-
sion not to complete a pregnancy has been largely elimi-
nated. This survey excluded any delay due to the
administrative process of notification of tuberculosis in
the pregnant population (a possible explanation for the
data in reference 21), having access to the primary clin-
ical record. Despite the clinics having different numbers
of patients with tuberculosis and different health
systems, a consistent finding has been that tuberculosis
is more likely to be diagnosed in the postpartum period
than during pregnancy itself.
This was an observational study using data obtained
during normal clinical practice. As such, it was
dependent on the accuracy of the medical record made
by the clinical physician and ignores any bias due to
access to health care. Use of the national crude birth rate
might account for the significant differences among the
clinics between the predicted and the observed numbers
of those who had been pregnant and had a history of
tuberculosis. For instance, the national crude birth rate
in the United Kingdom was 12 per 1,000, but was 18 per
1,000 in the location of the UK clinic. Moreover, the
birth rate is higher in those who have recently arrived in
the UK and the incidence of tuberculosis is also higher
in these populations. Follow-up of those who have com-
pleted treatment for tuberculosis is likely uncommon
(follow-up is not recommended in the NICE guidelines
relevant to this survey [35]) and the data for being preg-
nant within 3 months of completing treatment could
have been underestimated.
Generalisability
The study was undertaken in European countries with a
high (Belarus, Ukraine), medium (Serbia, Slovakia, UK)
and low (Italy, Belgium) incidence of tuberculosis.
Different health systems cover the various countries,
ranging from free universal access in the UK to one
where the majority pay for health insurance in the USA,
where the percentage of contribution to health spending
ranges from 96.9 to 45 % respectively [36]. This suggests
that there is a general delay in the diagnosis of tubercu-
losis in pregnancy which is unrelated to incidence and
health care system.
Conclusions
There remains a delay in the diagnosis of tuberculosis in
pregnancy. Screening for tuberculosis and encouraging
antenatal care in high-risk populations may both be
important to reduce morbidity due to tuberculosis.
Although tuberculosis may be more common in preg-
nancy, our data do not support a higher rate than
expected from the crude birth rate.
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